Longitude Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 20

Professionals
  • Investments
  • 133

  • Portfolio
  • 39

  • Exits
  • 84

Exits

Longitude Capital General Information

Description

Founded in 2006, Longitude Capital is a venture capital firm based in Menlo Park, California. The firm seeks to make investments in start-ups to growth companies in pharmaceuticals, biotechnology, healthcare devices, and life sciences sectors.

Contact Information

Year Founded
2006
Investor Status
Actively Seeking New Investments
Trade Association
New England Venture Capital Association (NEVCA)
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • 2740 Sand Hill Road
  • 2nd Floor
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000

Longitude Capital Investments (133)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
IntelyCare 06-Apr-2022 Later Stage VC 00000 Other Healthcare Technology Systems Generating Revenue
0000000 05-Apr-2022 00000 00000 0000 Therapeutic Devices Generating Revenue 0000000 000000
00 00000 000000 00 15-Mar-2022 00000 00000 00.000 Practice Management (Healthcare) Generating Revenue
0000000 23-Feb-2022 00000 00000 00000 Clinics/Outpatient Services Generating Revenue 0000000 00000000 00
0000 15-Feb-2022 00000 00000 00000 Therapeutic Devices Generating Revenue 000000 000000
00000000 000000000 22-Jan-2022 00000 00000 00000 Drug Discovery Clinical Trials - Phase 2 0000000 0000000
000000 000 05-Jan-2022 00000 00000 0000 Drug Discovery Generating Revenue 0000 0000000000 00
0000000 0000000000 16-Nov-2021 00000 00000 0000 Drug Discovery Generating Revenue 0000 0000000000 00
Quanta Therapeutics 26-Oct-2021 Later Stage VC 0000 Biotechnology Pre-Clinical Trials
Lexeo Therapeutics 09-Sep-2021 Later Stage VC 00000 Biotechnology Generating Revenue 000000 00000000
You’re viewing 10 of 133 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Longitude Capital Exits (84)

Company Name Exit Date Exit Type Exit Size
Velicept Therapeutics 01-Jul-2022 Out of Business
00000 30-Jun-2022 000000 0000000000 000.00
000000 00000000 30-Jun-2022 000000000000000000 00.00
000000000 00000000 31-May-2022 000000000000000000 00000
0000 000000000000 11-Feb-2022 000000 0000000000 000.00
000000 00000000000 08-Feb-2022 000000000000000000 00.000
00000 31-Dec-2021 000 00 00000000
00000000 0000 0000 17-Dec-2021 000000000000000000 00.000
Theseus 07-Oct-2021 IPO 00000
Encore Dermatology 20-Sep-2021 Out of Business
You’re viewing 10 of 84 exits. Get the full list »

Longitude Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Longitude Capital‘s full profile, request access.

Request a free trial

Longitude Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Longitude Capital Team (44)

Name Title Deals Funds Boards Office
Carolyn Helms Chief Financial Officer Menlo Park, CA
David Hirsch Ph.D Co-Founder & Managing Director 00 0 0 Boston, MA
Juliet Bakker Co-Founder & Managing Director 00 0 0 Greenwich, CT
Marc Galletti Co-Founder & Managing Director 0 0 0 Menlo Park, CA
Gregory Grunberg MD Managing Director 00 0 0 Menlo Park, CA
You’re viewing 5 of 44 team members. Get the full list »

Longitude Capital Co-Investors (167)

Name With Exits Lead Partner Series Industry
RA Capital Management 6 0 Series chart Industry bar
Sofinnova Investments 0 0 0 Series chart Industry bar
New Enterprise Associates 0 0 0 Series chart Industry bar
Omega Funds 0 0 0 Series chart Industry bar
T. Rowe Price 0 0 0 Series chart Industry bar
You’re viewing 5 of 167 co-investors. Get the full list »